VRE, or vancomycin-resistant enterococci, is a type of bacteria that has developed resistance to the antibiotic vancomycin, making it a significant concern in healthcare settings. It can cause a range of infections, particularly in patients with weakened immune systems. VRE is important to monitor due to its implications for treatment options and infection control.
“The first reports of Vancomycin resistant bacteria emerged in France in 1986. Not with Staph but another pesky bug called Enterococcus faecium: Vancomycin-resistant enterococci or VRE.”
“The first reports of Vancomycin resistant bacteria emerged in France in 1986. Not with Staph but another pesky bug called Enterococcus faecium: Vancomycin-resistant enterococci or VRE.”